Back
MediPharm Labs Vs. Lexaria Bioscience Industry Stock Comparison
Sell
32
MEDIF
MediPharm Labs
Last Price:
0.06
Seasonality Move:
-12.75%
Sell
36
LEXX
Lexaria Bioscience
Last Price:
3.16
Seasonality Move:
-12.01%
Sell
32
MediPharm Labs (MEDIF)
is a Sell
Is MediPharm Labs a Buy, Sell or Hold?
- The current MediPharm Labs [MEDIF] share price is $0.06. The Score for MEDIF is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
- MEDIF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
36
Lexaria Bioscience (LEXX)
is a Sell
Is Lexaria Bioscience a Buy, Sell or Hold?
- The current Lexaria Bioscience [LEXX] share price is $3.14. The Score for LEXX is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
- LEXX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
MEDIF Stock Price Chart
What is MediPharm Labs's stock price today?
-
The MediPharm Labs share price today is $0.06
The current trend is moderately bearish and MEDIF is experiencing selling pressure, which indicates risk of future bearish movement.
LEXX Stock Price Chart
What is Lexaria Bioscience's stock price today?
-
The Lexaria Bioscience share price today is $3.14
The current trend is moderately bullish and LEXX is experiencing slight buying pressure.
MEDIF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0 | Buy |
| Relative Strength Index (14 RSI): | 47.07 | Sell |
| Chaikin Money Flow: | -102896 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.06 - 0.06) | Sell |
| Bollinger Bands (100): | (0.04 - 0.06) | Buy |
LEXX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.11 | Buy |
| Relative Strength Index (14 RSI): | 52.18 | Buy |
| Chaikin Money Flow: | 33511 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.23 - 3.33) | Buy |
| Bollinger Bands (100): | (1.57 - 3.61) | Buy |
MEDIF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.06 | Sell |
| 20-day SMA: | 0.06 | Sell |
| 50-day SMA: | 0.06 | Buy |
| 200-day SMA: | 0.05 | Buy |
| 8-day EMA: | 0.06 | Sell |
| 20-day EMA: | 0.06 | Sell |
| 50-day EMA: | 0.06 | Sell |
| 200-day EMA: | 0.06 | Buy |
LEXX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.32 | Sell |
| 20-day SMA: | 2.93 | Buy |
| 50-day SMA: | 3.26 | Sell |
| 200-day SMA: | 1.87 | Buy |
| 8-day EMA: | 3.2 | Sell |
| 20-day EMA: | 3.08 | Buy |
| 50-day EMA: | 2.95 | Buy |
| 200-day EMA: | 2.27 | Buy |
MediPharm Labs Earnings Growth & MEDIF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Lexaria Bioscience Earnings Growth & LEXX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.43 per share, and an increase next year of $0.09 per share.
MediPharm Labs Technical Analysis
| May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Lexaria Bioscience Technical Analysis
| May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||